Listerine is owned by Kenvue (the United States, NYSE: KVUE), which was separated from Johnson & Johnson on 23 August 2023.[1][2] Before Kenvue, Listerine was owned by Johnson & Johnson from 2006 to 2023.[2]
Listerine was formulated in 1879 as a surgical antiseptic and named after Joseph Lister, the pioneer of antiseptic surgery. It was sold as a floor cleaner and a cure for gonorrhoea before its makers marketed it in the 1920s against halitosis, a campaign credited with popularising the very idea of bad breath as a social problem.
Kimberly-Clark agreed to acquire Kenvue in a cash and stock transaction that would combine Huggies and Kleenex with Tylenol, Listerine and Neutrogena. The deal is subject to shareholder and regulatory approvals.
Johnson & Johnson separated its consumer health business as Kenvue, which listed in May 2023 and was fully split off through an exchange offer completed on 23 August 2023. Tylenol, Band-Aid, Listerine, Neutrogena and Johnson's Baby all moved to the new company.